Abstract-Composition of atherosclerotic arterial walls is rich in lipids such as cholesterol; unlike normal arterial walls. In this study, we aimed to utilize this difference to diagnose atherosclerosis via multispectral imaging, which allows for identification of fluorescence originating from the substance in the arterial wall. The inner surface of extracted arteries (rabbit abdominal aorta, human coronary aorta) was illuminated by an excitation light and multispectral fluorescence images were obtained. The fluorescence spectra in atherosclerotic sites were shown to be different from those in normal sites. A ratio of fluorescence intensity at a wavelength of two significant differences was then calculated for each pixel and ratio images were reconstructed. As a result, we succeeded in "disease mapping", by which atherosclerotic sites can be discriminated from normal sites. The differences in fluorescence spectra may be attributed to the differences in fluorophores contained in the intima/media of the artery.
I. INTRODUCTION
Cardiovascular diseases (CVD) killed an approximate 17.5 million people worldwide in 2012. CVD is the leading cause of death globally and makes up three in every 10 deaths [1] . Of this number, 7.4 million people died of ischemic heart disease. Atherosclerosis is a known precursor of ischemic heart disease and is defined as the thickening or stiffening of arteries with plaque -restricting blood flow from the heart to other organs and tissues. This occurrence is often triggered by high blood pressure or hyperglycemia. However, if detected early, atherosclerosis is reversible [2] .
Current methods of diagnosing atherosclerosis are based on personal and family medical histories in addition to a physical examination involving listening to the heart and lungs via a stethoscope. As these methods are not decisive, suspected atherosclerosis is then followed by imaging tests that indicate blood flow in the arteries. In the present study, we propose diagnosis of atherosclerosis using multispectral imaging technology.
Arterial wall in atherosclerosis contains high levels of lipid, mostly cholesterol (Fig. 1) . This suggests the potential of diagnosing atherosclerosis based on biochemical properties. Multispectral imaging is a technique of image processing and /or analysis. The principle behind this method is such that when a sample is irradiated with excitation light, each point or pixel produces its corresponding reflection spectrum. In some cases, fluorescence spectrum is obtained. Therefore, spectral information can be obtained at each separate point (pixel) of the sample. This technology is often used in geographical analysis by satellites and also in remote sensing for detecting freshness of foods. Recently, multispectral imaging has also been emerging as a diagnostic method in the field of medicine. Hence, in this experiment, we hypothesize that multispectral fluorescence imaging can be used in detecting biochemical properties of arteries, which can subsequently be used in diagnosing atherosclerotic lesion.
II. MATERIALS & METHODS

A. Analysis of Atherosclerotic Aorta in Rabbits
Four-week-old rabbits (Oryctolagus cuniculus) were administered with a 1% cholesterol-containing feed for 27 weeks prior to aorta extraction. This resulted in atherosclerosis being developed in almost all the animals. For the purpose of this study, the abdominal aorta was extracted.
Isolated aorta was irradiated with 405 nm excitation light as shown in Fig. 2 . The multispectral fluorescence imaging system used had a spatial resolution of 1024 1024 pixels for a resulting fluorescence spectra of approximately one million pixels, with each pixel having a fluorescence spectrum range of 450 nm to 800 nm (Fig. 3) .
This study was conducted in accordance to the guidelines of the Institutional Review Board for the care of animals at the National Defense Medical College, Japan.
B. Application to Human Atherosclerotic Coronory Artery
Coronary arteries were extracted from human cadavers and analyses were carried out on blood vessels in the luminal surface (n = 10).
The protocol was approved by the ethics committee at National Defense Medical College, Tokorozawa.
III. RESULTS
A. Analysis of Fluorescence Spectra
In the rabbit abdominal aorta sample, comparison of the fluorescence spectra indicated that the fluorescence intensity at 505 nm (FL505) at atherosclerotic sites was a quarter than that of at normal sites. This level of fluorescence intensity was therefore used as an identifier in the rabbit aorta samples. Additionally, a small fluorescence peak at 615 nm (FL615) was also identified only in atherosclerotic samples.
As shown in Fig. 4 , in human coronary artery samples, the fluorescence intensity at 515 nm (FL515) was found to correspond to the 505 nm fluorescence intensity in the rabbit samples and was therefore used as an identifier. On the other hand, fluorescence intensities in the band of 630-800 nm were almost the same in both atherosclerotic samples and normal samples.
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B. Atheromatous Index
Spectral analysis of the human coronary arteries suggested that the discrimination between atherosclerotic and normal sites can be achieved using the ratio imaging (atheromatous ratio or AT ratio) derived by using equation (1) . (1) The resulting AT ratio value was then used in producing a reconstructed ratio image or "disease map" (Fig. 5) . Similar to the human cases, it was discovered in rabbit samples that the reconstructed image clearly discriminated between atherosclerotic sites and normal sites as shown in Fig. 6 . A pathological examination of human samples (HematoxylinEosin (HE) stain) revealed that the thickness of artery was highly associated with the depth of atheromatous plaque. Therefore, we then examined the relation between AT ratio and the depth of the atheromatous lesion that was speculated from the thickness of the artery based on the AT ratio of the samples with respect to that of the reference group (~1.0 mm). It was found that the thickness of the artery was almost correlated with AT ratio, suggesting that AT ratio may correspond to the depth of atheromatous lesion (Table 1) .
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Atherosclerotic Sample Photo Imaging Figure 6 : Reconstructed mapping of rabbit aorta samples. In this case, red colored areas correspond to normal site.
IV. DISCUSSION
Methods of detecting atherosclerotic lesion used at present are limiting and often not entirely conclusive. However, it is expected that the use of the current imaging technology in diagnosis may provide a quick and simple means to both detection and quantification of atherosclerotic lesion. The application of multispectral fluorescent imaging will provide more informative data on the biochemical composition of the lumen and vessel wall, which is easy to interpret and validate. This can greatly assist in both primary and secondary treatment of ischemic heart disease. We have demonstrated that multispectral fluorescence imaging is a viable method of detecting atherosclerosis sites. In the present study, the fluorescence peak at 505 nm in rabbit abdominal aorta and 515 nm in human coronary aorta was a key indicator for tissue discrimination and where difference in wavelength indicator is due to species difference. Candidate fluorophores that emit fluorescence at these wavelengths include collagen, elastin, FAD, etc. [4] [5] [6] . Furthermore, this study also suggests the possibility of quantitative evaluation of atherosclerosis using multispectral fluorescence imaging. As previously stated, the key indicator wavelength value was then used with the value at 630 nm where fluorescence intensities were almost the same in both normal and atherosclerotic samples in addition to being the beginning of the ending of the 505-515 nm fluorescence peak. Based on the data, we were able to successfully estimate the relative thickness of the artery (Table 1) . This may aid in the evaluation of progression of the atherosclerotic lesion.
Based on the results of this experiment, we intend to apply multispectral fluorescence technology in order to construct an endoscope-based diagnostic system for the in vivo detection of atherosclerotic lesion.
